Abstract

The Global Lung Cancer Coalition (GLCC) is a partnership of 42 patient organisations across 30 nations dedicated to improving outcomes for lung cancer patients. During the COVID-19 pandemic, many lung cancer patients were offered virtual (telephone or video) consultations alongside or instead of face-to-face appointments. Reasons included protecting patients from exposure to the virus, saving travel time, and freeing-up clinical time. As health systems explore the potential of hybrid systems of telemedicine post-COVID-19, the GLCC wanted to understand patients’ preferences for speaking to their treatment team and how they felt about virtual consultations.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call